These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 25880279)

  • 1. Targeting mitosis-regulating genes in cisplatin-sensitive and -resistant melanoma cells: A live-cell RNAi screen displays differential nucleus-derived phenotypes.
    Erfle H; Pashayeva K; Harder N; Zhang L; Rohr K; Schadendorf D; Ugurel S; Keese M
    Biotechnol J; 2015 Sep; 10(9):1467-77. PubMed ID: 25880279
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drug resistance towards etoposide and cisplatin in human melanoma cells is associated with drug-dependent apoptosis deficiency.
    Helmbach H; Kern MA; Rossmann E; Renz K; Kissel C; Gschwendt B; Schadendorf D
    J Invest Dermatol; 2002 Jun; 118(6):923-32. PubMed ID: 12060385
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combined effect of proteasome and calpain inhibition on cisplatin-resistant human melanoma cells.
    Młynarczuk-Biały I; Roeckmann H; Kuckelkorn U; Schmidt B; Umbreen S; Gołab J; Ludwig A; Montag C; Wiebusch L; Hagemeier C; Schadendorf D; Kloetzel PM; Seifert U
    Cancer Res; 2006 Aug; 66(15):7598-605. PubMed ID: 16885359
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The altered apoptotic pathways in cisplatin and etoposide-resistant melanoma cells are drug specific.
    Kissel CK; Schadendorf D; Röckmann H
    Melanoma Res; 2006 Dec; 16(6):527-35. PubMed ID: 17119454
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of gene expression profiles in melanoma cells with acquired resistance against antineoplastic drugs.
    Györffy B; Serra V; Materna V; Schäfer R; Dietel M; Schadendorf D; Lage H
    Melanoma Res; 2006 Apr; 16(2):147-55. PubMed ID: 16567970
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Candidate genes for cross-resistance against DNA-damaging drugs.
    Wittig R; Nessling M; Will RD; Mollenhauer J; Salowsky R; Münstermann E; Schick M; Helmbach H; Gschwendt B; Korn B; Kioschis P; Lichter P; Schadendorf D; Poustka A
    Cancer Res; 2002 Nov; 62(22):6698-705. PubMed ID: 12438269
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lentivirus-Mediated RNAi silencing targeting ERCC1 reverses cisplatin resistance in cisplatin-resistant ovarian carcinoma cell line.
    Du P; Zhang X; Liu H; Chen L
    DNA Cell Biol; 2015 Jul; 34(7):497-502. PubMed ID: 25941922
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alterations of DNA repair in melanoma cell lines resistant to cisplatin, fotemustine, or etoposide.
    Rünger TM; Emmert S; Schadendorf D; Diem C; Epe B; Hellfritsch D
    J Invest Dermatol; 2000 Jan; 114(1):34-9. PubMed ID: 10620112
    [TBL] [Abstract][Full Text] [Related]  

  • 9. FTY720 and cisplatin synergistically induce the death of cisplatin-resistant melanoma cells through the downregulation of the PI3K pathway and the decrease in epidermal growth factor receptor expression.
    Ishitsuka A; Fujine E; Mizutani Y; Tawada C; Kanoh H; Banno Y; Seishima M
    Int J Mol Med; 2014 Oct; 34(4):1169-74. PubMed ID: 25109763
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IGFBP-3 hypermethylation-derived deficiency mediates cisplatin resistance in non-small-cell lung cancer.
    Ibanez de Caceres I; Cortes-Sempere M; Moratilla C; Machado-Pinilla R; Rodriguez-Fanjul V; Manguán-García C; Cejas P; López-Ríos F; Paz-Ares L; de CastroCarpeño J; Nistal M; Belda-Iniesta C; Perona R
    Oncogene; 2010 Mar; 29(11):1681-90. PubMed ID: 20023704
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human melanoma cell lines selected in vitro displaying various levels of drug resistance against cisplatin, fotemustine, vindesine or etoposide: modulation of proto-oncogene expression.
    Kern MA; Helmbach H; Artuc M; Karmann D; Jurgovsky K; Schadendorf D
    Anticancer Res; 1997; 17(6D):4359-70. PubMed ID: 9494534
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gene expression response to cisplatin treatment in drug-sensitive and drug-resistant ovarian cancer cells.
    Li J; Wood WH; Becker KG; Weeraratna AT; Morin PJ
    Oncogene; 2007 May; 26(20):2860-72. PubMed ID: 17072341
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human melanoma cells selected for resistance to apoptosis by prolonged exposure to tumor necrosis factor-related apoptosis-inducing ligand are more vulnerable to necrotic cell death induced by cisplatin.
    Zhang XD; Wu JJ; Gillespie S; Borrow J; Hersey P
    Clin Cancer Res; 2006 Feb; 12(4):1355-64. PubMed ID: 16489094
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of c-FLIP in cisplatin resistance of human bladder cancer cells.
    Lee S; Yoon CY; Byun SS; Lee E; Lee SE
    J Urol; 2013 Jun; 189(6):2327-34. PubMed ID: 23313194
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Establishment of a human nasopharyngeal carcinoma drug-resistant cell line CNE2/DDP and screening of drug-resistant genes].
    Jiang RD; Zhang LX; Yue W; Zhu YF; Lu HJ; Liu X; Cen XT; Guan XY; Li CH
    Ai Zheng; 2003 Apr; 22(4):337-45. PubMed ID: 12703984
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypoxia-induced resistance to cisplatin and doxorubicin in non-small cell lung cancer is inhibited by silencing of HIF-1alpha gene.
    Song X; Liu X; Chi W; Liu Y; Wei L; Wang X; Yu J
    Cancer Chemother Pharmacol; 2006 Dec; 58(6):776-84. PubMed ID: 16532342
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Downregulation of survivin expression enhances sensitivity of cultured uveal melanoma cells to cisplatin treatment.
    Li H; Niederkorn JY; Neelam S; Alizadeh H
    Exp Eye Res; 2006 Jul; 83(1):176-82. PubMed ID: 16584731
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A genome-wide RNAi screen identifies novel targets of neratinib resistance leading to identification of potential drug resistant genetic markers.
    Seyhan AA; Varadarajan U; Choe S; Liu W; Ryan TE
    Mol Biosyst; 2012 Apr; 8(5):1553-70. PubMed ID: 22446932
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Microarray analysis revealed dysregulation of multiple genes associated with chemoresistance to As(2)O(3) and increased tumor aggressiveness in a newly established arsenic-resistant ovarian cancer cell line, OVCAR-3/AsR.
    Ong PS; Chan SY; Ho PC
    Eur J Pharm Sci; 2012 Feb; 45(3):367-78. PubMed ID: 22178533
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cisplatin regulates the MAPK kinase pathway to induce increased expression of DNA repair gene ERCC1 and increase melanoma chemoresistance.
    Li W; Melton DW
    Oncogene; 2012 May; 31(19):2412-22. PubMed ID: 21996734
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.